How to create a logotype based on core values - A study of how craft companies can visually strengthen their brand identity

DIY- \u93Do it Yourself\u94 är en ny trend som går ifrån konsumtionssamhället för att istället värna om det genuina hantverket. Få studier har presenterat hur en visuell varumärkesidentitet bör utformas för att förtydliga dessa typer av verksamheter. Rapporten syftar till att undersöka hur en logotyp kan utformas för ett Hantverksföretag utifrån verksamhetens kärnvärden, för att skapa önskvärda associationer och därmed stärka varumärkets identitet. Under studien har arbetet genomförts utifrån ett \u93case-företag\u94 vid namn Hantverksgården. Genom företagets kärnvärden, genuint, lantligt och idylliskt har rapporten undersökt hur en logotyp bör utformas för att reflektera verksamheten. Genom att identifiera verksamheten och söka inspiration utifrån kärnvärdena togs två logotyper fram. För att besvara syftet värderades vardera logotyp med åtta respondenter. Logotyperna undersöktes utifrån sex kriterier minnesvärd, meningsfull, älskvärd, originalitet, skalbarhet/mångsidighet/överförbarhet och utförande. Studiens visade genom att framhäva verksamhetens ursprung skapades associationer till begreppet genuint. Kärnvärdet lantligt reflekterades genom avbildade objekt kopplade till verksamheten. Genom dekorativa illustrationer kunde logotypen uppfattas som idyllisk. Kriterierna älskvärd och meningsfull visades vara de viktigaste kriterierna för att uppfylla önskvärda associationer

"Alla kvinnor vill bli våldtagna” : En kritisk diskursanalys om våldtäkt

Syftet med den här studien är att undersöka diskurser kring våldtäkt och hur kvinnor framställs utifrån kön och sexualitet på internetforumet Flashback forum. Studiens frågeställningar är: Hur diskuteras det om våldtäkt på Flashback forum? Hur framställs kvinnor utifrån genus och sexualitet i diskussioner kring våldtäkt på Flashback forum? För att besvara studiens två frågeställningar insamlas textmaterial från Flashback forum. Studien är kvalitativ och (kritisk) diskursanalys används som metod. Materialet analyseras med hjälp av feministiska teorier med fokus på genus och sexualitet. Studiens resultat visar att diskursen som finns på Flashback forum många gånger skuldbelägger våldtäktsoffret. Detta görs genom att man bland annat ifrågasätter kvinnans klädsel, alkoholpåverkan och uppträdande i samband med en våldtäkt. Dessutom framkommer det att det är mannen som har tolkningsföreträde i fråga om att definiera vad manlighet och kvinnlighet är, samt vad som betraktas som sex och våldtäkt. Vidare visar resultaten att kvinnor förväntas uppträda på ett visst sätt utifrån normer kring genus och sexualitet. Exempelvis framställs kvinnans sexualitet som passiv, medan mannens sexualitet framställs som aktiv. I analysen tolkas detta som ett tecken på mannens tolkningsföreträde gällande kön och sexualitet, vilket i sin tur kan bidra till mannens överordning

Personalized Medicine

The aim of this project was to present several therapies and possible applications of these in the field of personalized medicine along with the production techniques and workflows surrounding them. There are two main categories; cell therapies and non-cell therapies. Cell therapies utilize the body's own T cells and immune system, and non-cell therapies are mostly based on proteins and nucleotides. All of these applications face different challenges that need to be overcome to be considered effective treatments and they all have a high production cost. The report also presents differences and similarities of manufacturing models that are specifically used in the production of cell therapies. It could be argued that these manufacturing models can be adjusted and work for both cell therapies and non-cell therapies. Three different workflows for three different personalized medicines, antibody drug conjugates (ADCs), tumor infiltrating lymphocytes (TILs) and mRNA vaccines, are presented in this report. Technologies and processes valuable to the manufacturing process were also presented, including bioreactors, interleukin 2 media and cell dissociation technologies. In conclusion, there are methods and techniques that are frequently used in production that are, or possibly could be useful for manufacturing personalized drug components. Production of products used in personalized medicine is possible if the right resources are available. Personalized therapies are presently most commonly applied to cancer diseases but there are developments for these therapies that could benefit several other diseases. To fully apply personalized therapies to these diseases further studies on suitable biomarkers and targets in drugs are needed. Overall, personalized medicine has promising possibilities in treatments for many types of complex diseases. This project was assigned by Cytiva which is a global life science company and the product order can be seen in the appendix

Personalized Medicine

The aim of this project was to present several therapies and possible applications of these in the field of personalized medicine along with the production techniques and workflows surrounding them. There are two main categories; cell therapies and non-cell therapies. Cell therapies utilize the body's own T cells and immune system, and non-cell therapies are mostly based on proteins and nucleotides. All of these applications face different challenges that need to be overcome to be considered effective treatments and they all have a high production cost. The report also presents differences and similarities of manufacturing models that are specifically used in the production of cell therapies. It could be argued that these manufacturing models can be adjusted and work for both cell therapies and non-cell therapies. Three different workflows for three different personalized medicines, antibody drug conjugates (ADCs), tumor infiltrating lymphocytes (TILs) and mRNA vaccines, are presented in this report. Technologies and processes valuable to the manufacturing process were also presented, including bioreactors, interleukin 2 media and cell dissociation technologies. In conclusion, there are methods and techniques that are frequently used in production that are, or possibly could be useful for manufacturing personalized drug components. Production of products used in personalized medicine is possible if the right resources are available. Personalized therapies are presently most commonly applied to cancer diseases but there are developments for these therapies that could benefit several other diseases. To fully apply personalized therapies to these diseases further studies on suitable biomarkers and targets in drugs are needed. Overall, personalized medicine has promising possibilities in treatments for many types of complex diseases. This project was assigned by Cytiva which is a global life science company and the product order can be seen in the appendix

Oat β-glucan containing bread increases the glycaemic profile

A net postprandial glucose increment beyond 2 h has been shown to improve glucose and appetite regulation at a subsequent meal. Such an improved glycaemic profile (GP) has been reported for bread containing guar gum. In the present study three commercially available β-glucans from barley and oat were baked into yeast leavened bread products. Only oat beta-glucan containing bread met the criteria of β-glucan molecular weight and was included in a meal study. The three levels of oat β-glucans reduced the GI and glucose iPeak by 32–37% compared to a white wheat reference bread. Furthermore, the highest oat β-glucan level increased GP by 66% compared to the reference bread. It is concluded that the oat β-glucans were suitable for use in baking, since the MW remained relatively high. Thus, the oat ingredient showed an interesting potential to be used when tailoring the glycaemic profile of bread products

Economic burden of sickle cell disease in Sweden : a population-based national register study with 13 years follow up

Introduction: Sickle cell disease (SCD) describes a group of inherited disorders of hemoglobin. Globally, SCD occurs in approximately 300,000-400,000 births annually and is most prevalent in malaria-endemic countries. However, migration has impacted the epidemiology of SCD but data on the matter are scarce. The objective of this study was to describe the epidemiology, treatment uptake, and economic burden of SCD in Sweden, a country with substantial immigration over the last decades. Methods: This nationwide retrospective observational registry cohort study identified patients with SCD from 2001 to 2018 and followed them from 2006 to 2018. Using data from high-quality population-based Swedish registers, we estimated prevalence, treatment uptake, and SCD-related health care resource use, sick leave and disability pension. Results: Between 2006 and 2018 the number of patients with SCD increased from 504 to 670; inpatient hospital stays and outpatient visits increased by 200% and 300%, respectively. Patients with pain crises had approximately twice the number of inpatient episodes and outpatient visit per year, and had higher productivity losses compared to patients without crises. Conclusion: In an era of emerging treatments for SCD, we have, to the best of our knowledge, for the first time comprehensively described epidemiological and economic aspects of SCD in a country where the disease is still rare and not well recognized by the healthcare system